https://www.avient.com/sites/default/files/2022-05/Glucose Monitoring App Snapshot.pdf
Glucose Monitoring App Snapshot draft
MEDICAL DEVICE OEM
C O N T I N U O U S G L U C O S E
M O N I T O R I N G S Y S T E M
• Adapt to strict processing requirements of a secondary
operation put in place to manufacture a new device model
• Meet material size and thickness requirements while
achieving desired color target
• Overcome material unpredictability and sensitivity to heat,
light and moisture
• Minimize impact of supply chain instability and changes
• Offered support for processing under low
pressure conditions and at every stage of
manufacturing
• Performed extensive R&D work to
consistently deliver the customer’s color
target of a hard-to-achieve light gray
• Effectively addressed all material challenges
and sensitivities
• Provided regular ‘summaries of
understanding’ to keep up with changing
forecasts and ordering patterns
Mevopur™ Pre-color Formulation
KEY REQUIREMENTS
WHY AVIENT?
AVIENT SOLUTION
PROCESSING + MATERIAL PERFORMANCE
LEARN MORE
© 2022, Avient Corporation, All Rights Reserved.
https://www.avient.com/sites/default/files/2024-12/Rejoin PCR Colorants - Recycled Printer Cover - case study snapshot.pdf
Home printer OEM
HOME PRINTER
OEM
R E C Y C L E D H I P S I N J E C T I O N
C O V E R O F P R I N T E R
• Provide PCR-based colorants for a more sustainable
solution
• Meet both color and mechanical requirements in PCR
materials
• Offer user-friendly PCR + Colorants solution to address
the batch variance problem of PCR in an economical way
• Offered revolutionary supply model of PCR
+ Colorants, ensuring precise quality and
color
• Helped customers solve the batch variance
problem of PCR in a digital way and
shortened the color-matching time with PCR
Color Prediction Service
• Provided on-site technical support to
customer
Rejoin PCR Colorants
KEY REQUIREMENTS
WHY AVIENT?
AVIENT SOLUTION
PCR BASED COLORANTS + QUALITY
LEARN MORE
Copyright © 2024, Avient Corporation.
https://www.avient.com/sites/default/files/2024-11/Avient Announces Registration Details for December 4th Investor Day.pdf
Ashish Khandpur, President and Chief Executive Officer of Avient
Corporation.
Investor Relations Contact:
Giuseppe (Joe) Di Salvo
Vice President, Treasurer and Investor Relations
Avient Corporation
+1 440-930-1921
giuseppe.disalvo@avient.com
Media Contact:
Kyle G.
Rose
Vice President, Corporate Communications
Avient Corporation
+1 440-930-3162
kyle.rose@avient.com
https://www.avient.com/sites/default/files/2022-08/Avient CDP_Climate_Change_Questionnaire_2022.pdf
Position of individual(s) Please explain
Chief Executive Officer
(CEO)
Climate-related issues are the responsibility of Avient’s Chief
Executive Officer (CEO), who has been a member of Avient’s Board
of Directors (BOD) since 2014.
Where in the organizational structure this position (s) and / or committee (s) lie:
Corporate sustainability and climate-related issues are the responsibility of Avient’s highest-
level officer, our Chairman, President and Chief Executive Officer (CEO), who is also a member
of the Board of Directors.
Job title Corresponding job category
Row 1 VP Sustainability Chief Sustainability Officer (CSO)
SC.
https://www.avient.com/sites/default/files/2020-07/case-study-one-pager-versaflex-dog-toy.pdf
PET SUPPLY
MANUFACTURER
D O G T O Y
• Tear strength
• Durability
• Colorability
• Formulation must not intentionally contain BPA, heavy
metals, latex, natural rubber, phthalates, or SVHC
(REACH)
• Optimized material processing and tooling
through technical services and application
development support
• Delivered a solution to address regulation
and consumer safety concerns
Versaflex™ Thermoplastic Elastomer
KEY REQUIREMENTS WHY AVIENT?
AVIENT SOLUTION
STRENGTH + SAFETY
LEARN MORE
Copyright © 2020, Avient Corporation.
https://www.avient.com/sites/default/files/2023-07/Avient_CodeConduct_2023_Swedish.pdf
Det är
bäst att gå igenom Avients policyer rörande gåvor
och diskutera idén med din chef eller Corporate
Ethics Officer innan du skickar någonting.
Dessa rapporter ska skickas in för
lösning, skriftligen, till juridikavdelningen eller Corporate
Ethics Officer.
Ett oberoende bolag tar emot alla
Webb- och telefonrapporter till Ethics Hotline och rapporterar informationen till Corporate Ethics Officer.
https://www.avient.com/sites/default/files/2020-10/neu-quality-commitment.pdf
This document is property
of Avient Corporation and may not be reproduced or communicated to third parties without authorization.
This document is property
of Avient Corporation and may not be reproduced or communicated to third parties without authorization.
4.1.5 Packaging may include a liner or pallet based on the configuration.
This document is property
of Avient Corporation and may not be reproduced or communicated to third parties without authorization.
5.5 Regulatory Documents: A document referencing the then-current regulatory status of
the applicable product(s) at the time of shipment.
https://www.avient.com/products/thermoplastic-elastomers/onflex-thermoplastic-elastomers
Learn about overmolding, material selection to enhance function, and design considerations that can help you address challenges and delight customers
https://www.avient.com/products/thermoplastic-elastomers/dynaflex-thermoplastic-elastomers
Learn about overmolding, material selection to enhance function, and design considerations that can help you address challenges and delight customers
https://www.avient.com/sites/default/files/2024-07/TPE Whitepaper_0.pdf
Additionally, TPEs help
to generate lead-time enhancements and feed
into capacity utilization improvements.
3© 2020 Avient Corporation, 33587 Walker Road, Avon Lake, Ohio USA 44012
3.
Medical
grade TPEs have extremely low levels of leachables and extractables, and
are available in several different formulations to address specific processing
and end product requirements.
4© 2020 Avient Corporation, 33587 Walker Road, Avon Lake, Ohio USA 44012
CASE IN POINT: STOPPERS AND SEPTUMS
Versaflex™ HC TPE from Avient offers customers an exceptional
alternative to rubber for septums and stoppers.
You have an opportunity to drive growth by addressing global demand
for your products, which is spiking in direct response to the needs of
elderly patients and the increasing number of middle-class consumers
in China, India and Brazil, among other nations.